FAM138F: A Potential Drug Target and Biomarker for the Treatment of Inflammatory Diseases

Target Name: FAM138F

NCBI ID: G641702

FAM138F

Other Name(s): F379 | Family with sequence similarity 138 member F | family with sequence similarity 138 member F

FAM138F: A Potential Drug Target and Biomarker for the Treatment of Inflammatory Diseases

Abstract:

FAM138F, a member of the FAM138 family of proteins, has been identified as a potential drug target and biomarker for the treatment of inflammatory diseases. Its unique structure and various post-translational modifications (PTMs) make it an attractive target for small molecules. In this article, we will discuss the current research on FAM138F, its potential drug targets, and its potential as a biomarker for the diagnosis and monitoring of inflammatory diseases.

Introduction:

Inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease, and chronic obstructive pulmonary disease (COPD), cause significant morbidity and mortality worldwide. These diseases are characterized by chronic inflammation and an imbalance in the immune system, leading to the production of pro- inflammatory cytokines. FAM138F, a member of the FAM138 family of proteins, has been identified as a potential drug target and biomarker for the treatment of inflammatory diseases due to its unique structure and various post-translational modifications (PTMs).

Structure and Function:

FAM138F is a 14 kDa protein that belongs to the FAM138 family, which is characterized by the presence of a nucleotide-binding oligomerization domain (NBD) and a carboxy-terminal hypervariable region (CTHR). The NBD is a common structural feature that involves the formation of a nucleotide-protein complex, which can modulate protein stability and function. The CTHR is a variable region that can be modified by various post-translational modifications, including tyrosination, phosphorylation, and ubiquitination, among others.

FAM138F has been shown to play a role in various cellular processes, including cell signaling, DNA replication, and cell survival. It has also been shown to be involved in the regulation of inflammation, immune response, and cellular stress. The NBD and CTHR of FAM138F have been identified as potential drug targets for the treatment of inflammatory diseases.

Potential Drug Targets:

FAM138F can be targeted by small molecules due to its unique structure and various PTMs. One of the most promising drug targets is the NBD, which can be modulated by small molecules to alter the activity and stability of FAM138F. The NBD has been shown to play a role in the regulation of protein stability and function, and small molecules that can modulate its activity may have therapeutic benefits for inflammatory diseases.

Another potential drug target is the CTHR, which can be modified by small molecules to alter the activity and stability of FAM138F. The CTHR has been shown to play a role in the regulation of protein stability and function, and small molecules that can modify its activity may have therapeutic benefits for inflammatory diseases.

Potential Biomarkers:

FAM138F can be used as a biomarker for the diagnosis and monitoring of inflammatory diseases due to its unique structure and various PTMs. One of the most promising biomarkers is the NBD, which can be used as a marker for the activity of FAM138F and its potential therapeutic benefits for inflammatory diseases. The NBD has been shown to be involved in the regulation of protein stability and function, and small molecules that can modulate its activity may have therapeutic benefits for inflammatory diseases.

Another promising biomarker is the CTHR, which can be used as a marker for the activity of FAM138F and its potential therapeutic benefits for inflammatory diseases. The CTHR has been shown to play a role in the regulation of protein stability and function, and small molecules that can modulate its activity may have therapeutic benefits for inflammatory diseases.

Conclusion:

FAM138F is a unique protein that has been identified as a potential drug target and biomarker for the treatment of inflammatory diseases due to its unique structure and various post

Protein Name: Family With Sequence Similarity 138 Member F

The "FAM138F Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM138F comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets